Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aspect Medical Systems Inc (ASPM) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Aspect Medical Systems Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 886235.
Total stock buying since 2005: $16,357,162.
Total stock sales since 2005: $12,324,241.
Total stock option exercises since 2005: $1,113,615.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2009 | 651,330 | $3,257,476 | 660,123 | $5,401,919 | 0 | $0 |
| 2008 | 720,471 | $3,953,783 | 218,771 | $1,415,466 | 62,767 | $248,049 |
| 2007 | 135,214 | $2,016,559 | 36,753 | $554,634 | 38,897 | $252,734 |
| 2006 | 2,000 | $44,000 | 121,938 | $2,771,897 | 106,083 | $612,832 |
| 2005 | 252,000 | $7,085,344 | 66,320 | $2,180,325 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2009-10 | 0 | $0 | 14,501 | $172,886 | 0 | $0 |
| 2009-09 | 0 | $0 | 254,996 | $2,973,272 | 0 | $0 |
| 2009-08 | 0 | $0 | 100,000 | $670,000 | 0 | $0 |
| 2009-07 | 0 | $0 | 5,000 | $32,500 | 0 | $0 |
| 2009-06 | 0 | $0 | 131,669 | $802,905 | 0 | $0 |
| 2009-05 | 51,330 | $263,476 | 15,101 | $92,551 | 0 | $0 |
| 2009-04 | 600,000 | $2,994,000 | 111,522 | $554,264 | 0 | $0 |
| 2009-02 | 0 | $0 | 27,334 | $103,541 | 0 | $0 |
| 2008-12 | 85,000 | $307,995 | 2,705 | $13,525 | 0 | $0 |
| 2008-07 | 0 | $0 | 3,500 | $21,199 | 3,500 | $14,700 |
| 2008-06 | 397,025 | $2,329,200 | 23,818 | $147,323 | 23,818 | $100,034 |
| 2008-05 | 229,446 | $1,211,936 | 152,361 | $786,182 | 0 | $0 |
| 2008-03 | 0 | $0 | 22,412 | $270,516 | 21,474 | $79,512 |
| 2008-02 | 9,000 | $104,652 | 13,975 | $176,721 | 13,975 | $53,803 |
| 2007-12 | 0 | $0 | 4,500 | $69,500 | 4,500 | $32,860 |
| 2007-09 | 0 | $0 | 5,877 | $72,867 | 3,646 | $13,829 |
| 2007-07 | 125,214 | $1,866,759 | 0 | $0 | 4,375 | $16,843 |
| 2007-05 | 0 | $0 | 15,000 | $233,249 | 15,000 | $146,999 |
| 2007-04 | 0 | $0 | 2,000 | $34,160 | 2,000 | $7,700 |
| 2007-03 | 0 | $0 | 9,376 | $144,858 | 9,376 | $34,503 |
| 2007-02 | 10,000 | $149,800 | 0 | $0 | 0 | $0 |
| 2006-12 | 0 | $0 | 2,000 | $41,000 | 0 | $0 |
| 2006-11 | 0 | $0 | 1,000 | $17,140 | 0 | $0 |
| 2006-08 | 0 | $0 | 0 | $0 | 3,000 | $11,040 |
| 2006-07 | 0 | $0 | 0 | $0 | 12,000 | $47,280 |
| 2006-06 | 0 | $0 | 34,900 | $685,267 | 24,500 | $91,919 |
| 2006-05 | 2,000 | $44,000 | 53,900 | $1,180,917 | 8,000 | $1,600 |
| 2006-04 | 0 | $0 | 12,916 | $359,387 | 9,583 | $55,993 |
| 2006-02 | 0 | $0 | 17,222 | $488,186 | 49,000 | $405,000 |
| 2005-10 | 0 | $0 | 6,320 | $207,635 | 0 | $0 |
| 2005-09 | 0 | $0 | 10,000 | $316,750 | 0 | $0 |
| 2005-08 | 0 | $0 | 30,000 | $989,960 | 0 | $0 |
| 2005-07 | 252,000 | $7,085,344 | 20,000 | $665,980 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-10-02 | Mahoney James J Jr (Director) | Sale | 6,501 | 11.95 | 77,686 |
| 2009-10-01 | Mahoney James J Jr (Director) | Sale | 8,000 | 11.90 | 95,200 |
| 2009-09-28 | Floyd William H (EVP, Worldwide Sales&Marketing) | Sale | 10,000 | 11.92 | 119,200 |
| 2009-09-28 | Coghill Clint D (10% Owner) | Sale | 230,000 | 11.92 | 2,741,600 |
| 2009-09-22 | Floyd William H (EVP, Worldwide Sales&Marketing) | Sale | 10,000 | 7.75 | 77,500 |
| 2009-09-18 | Floyd William H (EVP, Worldwide Sales&Marketing) | Sale | 1,228 | 7.00 | 8,596 |
| 2009-09-17 | Floyd William H (EVP, Worldwide Sales&Marketing) | Sale | 3,768 | 7.00 | 26,376 |
| 2009-08-25 | Coghill Clint D (10% Owner) | Sale | 100,000 | 6.70 | 670,000 |
| 2009-07-29 | Floyd William H (EVP, Worldwide Sales&Marketing) | Sale | 5,000 | 6.50 | 32,500 |
| 2009-06-26 | Juvonen Ronald (Other) | Sale | 129,839 | 6.10 | 792,017 |
| 2009-06-16 | Juvonen Ronald (10% Owner) | Sale | 100 | 5.95 | 595 |
| 2009-06-12 | Juvonen Ronald (10% Owner) | Sale | 1,730 | 5.95 | 10,293 |
| 2009-05-26 | Juvonen Ronald (10% Owner) | Sale | 100 | 5.95 | 595 |
| 2009-05-20 | Juvonen Ronald (10% Owner) | Sale | 15,001 | 6.13 | 91,956 |
| 2009-05-01 | First Manhattan Co. Inc (10% Owner) | Buy | 51,209 | 5.13 | 262,855 |
| 2009-05-01 | First Manhattan Co (10% Owner) | Buy | 121 | 5.13 | 621 |
| 2009-04-30 | First Manhattan Co. Inc (10% Owner) | Buy | 600,000 | 4.99 | 2,994,000 |
| 2009-04-30 | Coghill Clint D (10% Owner) | Sale | 111,522 | 4.97 | 554,264 |
| 2009-02-05 | Stanski Don (Director) | Sale | 27,334 | 3.79 | 103,541 |
| 2008-12-24 | Stanski Don (Director) | Buy | 4,000 | 3.20 | 12,792 |
| 2008-12-23 | Stanski Don (Director) | Buy | 6,000 | 3.15 | 18,918 |
| 2008-12-22 | Stanski Don (Director) | Buy | 6,000 | 3.25 | 19,500 |
| 2008-12-19 | O'connor John James (Director) | Buy | 2,000 | 3.60 | 7,200 |
| 2008-12-19 | Stanski Don (Director) | Buy | 6,000 | 3.56 | 21,378 |
| 2008-12-18 | O'connor John James (Director) | Buy | 43,000 | 3.67 | 157,767 |
| 2008-12-18 | Stanski Don (Director) | Buy | 6,000 | 3.76 | 22,560 |
| 2008-12-17 | Stanski Don (Director) | Buy | 6,000 | 4.04 | 24,228 |
| 2008-12-16 | Stanski Don (Director) | Buy | 6,000 | 3.94 | 23,652 |
| 2008-12-09 | Coghill Clint D (10% Owner) | Sale | 2,705 | 5.00 | 13,525 |
| 2008-07-02 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 3,500 | 6.06 | 21,199 |
| 2008-07-02 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Option Ex | 3,500 | 4.20 | 14,700 |
| 2008-06-30 | Coghill Clint D (10% Owner) | Buy | 5,000 | 6.38 | 31,900 |
| 2008-06-25 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 8,000 | 6.45 | 51,612 |
| 2008-06-25 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Option Ex | 8,000 | 4.20 | 33,599 |
| 2008-06-24 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 6.71 | 100,665 |
| 2008-06-23 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 6.69 | 98,708 |
| 2008-06-20 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 6.12 | 91,740 |
| 2008-06-20 | Coghill Clint D (10% Owner) | Buy | 1,000 | 6.03 | 6,030 |
| 2008-06-19 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 6.03 | 90,436 |
| 2008-06-19 | Coghill Clint D (10% Owner) | Buy | 70,000 | 6.03 | 422,100 |
| 2008-06-18 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 5.81 | 87,165 |
| 2008-06-18 | Coghill Clint D (10% Owner) | Buy | 10,634 | 5.71 | 60,720 |
| 2008-06-17 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 5.92 | 88,725 |
| 2008-06-17 | Coghill Clint D (10% Owner) | Buy | 5,200 | 5.84 | 30,368 |
| 2008-06-17 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 8,000 | 5.91 | 47,255 |
| 2008-06-17 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Option Ex | 8,000 | 4.20 | 33,600 |
| 2008-06-16 | Coolidge John (VP of Manufacturing) | Buy | 8,000 | 5.85 | 46,800 |
| 2008-06-16 | Floyd William H (VP of Sales and Marketing) | Buy | 15,000 | 5.93 | 88,950 |
| 2008-06-10 | Coghill Clint D (10% Owner) | Buy | 3,600 | 5.70 | 20,520 |
| 2008-06-09 | Coghill Clint D (10% Owner) | Buy | 20,000 | 5.65 | 113,000 |
| 2008-06-06 | Coghill Clint D (10% Owner) | Buy | 9,764 | 5.89 | 57,509 |
| 2008-06-05 | Coghill Clint D (10% Owner) | Buy | 7,900 | 6.21 | 49,059 |
| 2008-06-04 | Coghill Clint D (10% Owner) | Buy | 14,600 | 5.66 | 82,636 |
| 2008-06-03 | Coghill Clint D (10% Owner) | Buy | 58,623 | 5.48 | 321,254 |
| 2008-06-02 | Coghill Clint D (10% Owner) | Buy | 49,304 | 5.31 | 261,804 |
| 2008-05-22 | Coghill Clint D (10% Owner) | Buy | 99,446 | 5.35 | 532,036 |
| 2008-05-21 | Coghill Clint D (10% Owner) | Buy | 130,000 | 5.23 | 679,900 |
| 2008-05-19 | Juvonen Ronald (Other) | Sale | 152,361 | 5.16 | 786,182 |
| 2008-03-06 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 938 | 11.78 | 11,049 |
| 2008-03-03 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 12,499 | 12.08 | 151,018 |
| 2008-03-03 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Option Ex | 12,499 | 3.71 | 46,485 |
| 2008-02-19 | Mahoney James J Jr (Director) | Buy | 9,000 | 11.63 | 104,652 |
| 2008-02-04 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Sale | 9,375 | 12.63 | 118,357 |
| 2008-02-04 | Manberg Paul (VP of Clinical, Reg-Qual-Assur) | Option Ex | 9,375 | 3.85 | 36,093 |
| 2007-12-24 | Davidson Marc (VP of Engineering) | Sale | 2,500 | 15.00 | 37,500 |
| 2007-12-24 | Davidson Marc (VP of Engineering) | Option Ex | 2,500 | 10.20 | 25,500 |
| 2007-12-12 | Floyd William H (VP of Sales and Marketing) | Sale | 2,000 | 16.00 | 32,000 |
| 2007-12-12 | Floyd William H (VP of Sales and Marketing) | Option Ex | 2,000 | 3.68 | 7,360 |
| 2007-09-14 | Davidson Marc (VP of Engineering) | Sale | 1,138 | 12.34 | 14,042 |
| 2007-09-12 | Davidson Marc (VP of Engineering) | Sale | 4,739 | 12.41 | 58,825 |
| 2007-09-12 | Davidson Marc (VP of Engineering) | Option Ex | 3,646 | 3.79 | 13,829 |
| 2007-07-27 | Coghill Clint D (10% Owner) | Buy | 1,825 | 13.54 | 24,710 |
| 2007-07-26 | Coghill Clint D (10% Owner) | Buy | 2,200 | 13.88 | 30,536 |
| 2007-07-25 | Coghill Clint D (10% Owner) | Buy | 1,946 | 13.98 | 27,205 |
| 2007-07-24 | Coghill Clint D (10% Owner) | Buy | 16,456 | 14.83 | 244,042 |
| 2007-07-23 | Coghill Clint D (10% Owner) | Buy | 12,001 | 14.99 | 179,894 |
| 2007-07-20 | Coghill Clint D (10% Owner) | Buy | 72,831 | 14.97 | 1,090,644 |
| 2007-07-18 | Coghill Clint D (10% Owner) | Buy | 8,300 | 15.02 | 124,666 |
| 2007-07-17 | Coghill Clint D (10% Owner) | Buy | 3,445 | 15.10 | 52,019 |
| 2007-07-16 | Coghill Clint D (10% Owner) | Buy | 116 | 15.13 | 1,755 |
| 2007-07-11 | Coghill Clint D (10% Owner) | Buy | 6,094 | 14.98 | 91,288 |
| 2007-07-05 | Bollen Boudewijn L (Pres. International Oper.) | Option Ex | 4,375 | 3.85 | 16,843 |
| 2007-05-21 | Bollen Boudewijn L (Pres. International Oper.) | Sale | 12,832 | 15.55 | 199,537 |
| 2007-05-21 | Bollen Boudewijn L (Pres. International Oper.) | Option Ex | 12,832 | 9.80 | 125,753 |
| 2007-05-18 | Bollen Boudewijn L (Pres. International Oper.) | Sale | 2,168 | 15.55 | 33,712 |
| 2007-05-18 | Bollen Boudewijn L (Pres. International Oper.) | Option Ex | 2,168 | 9.80 | 21,246 |
| 2007-04-25 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 17.16 | 17,160 |
| 2007-04-25 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.85 | 3,850 |
| 2007-04-24 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 17.00 | 17,000 |
| 2007-04-24 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.85 | 3,850 |
| 2007-03-26 | Devlin Philip (VP of Neurodiagnostics) | Sale | 376 | 15.63 | 5,876 |
| 2007-03-26 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 376 | 3.68 | 1,383 |
| 2007-03-23 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.80 | 15,800 |
| 2007-03-23 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-22 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.74 | 15,742 |
| 2007-03-22 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-21 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.61 | 15,610 |
| 2007-03-21 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-20 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.50 | 15,500 |
| 2007-03-20 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-19 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.50 | 15,504 |
| 2007-03-19 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-16 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.16 | 15,160 |
| 2007-03-16 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-15 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.22 | 15,216 |
| 2007-03-15 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-14 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.07 | 15,070 |
| 2007-03-14 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-03-13 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 15.38 | 15,380 |
| 2007-03-13 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 1,000 | 3.68 | 3,680 |
| 2007-02-12 | Kania Ed (Director) | Buy | 10,000 | 14.98 | 149,800 |
| 2006-12-14 | Devlin Philip (VP of Neurodiagnostics) | Sale | 2,000 | 20.50 | 41,000 |
| 2006-11-03 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 17.14 | 17,140 |
| 2006-08-08 | Devlin Philip (VP of Neurodiagnostics) | Option Ex | 3,000 | 3.68 | 11,040 |
| 2006-07-26 | Chamoun Nassib (President and CEO) | Option Ex | 12,000 | 3.94 | 47,280 |
| 2006-06-09 | Devlin Philip (VP of Neurodiagnostics) | Sale | 1,000 | 18.29 | 18,290 |
| 2006-06-08 | Eagle J Breckenridge (Chairman of the Board) | Sale | 2,100 | 18.76 | 39,396 |
| 2006-06-08 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 2,100 | 3.68 | 7,728 |
| 2006-06-07 | Eagle J Breckenridge (Chairman of the Board) | Sale | 10,000 | 19.31 | 193,100 |
| 2006-06-07 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 10,000 | 3.68 | 36,800 |
| 2006-06-06 | Eagle J Breckenridge (Chairman of the Board) | Sale | 4,100 | 19.40 | 79,540 |
| 2006-06-06 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 4,100 | 3.77 | 15,436 |
| 2006-06-02 | Eagle J Breckenridge (Chairman of the Board) | Sale | 7,700 | 20.46 | 157,542 |
| 2006-06-02 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 7,700 | 3.85 | 29,645 |
| 2006-06-01 | Eagle J Breckenridge (Chairman of the Board) | Sale | 10,000 | 19.74 | 197,399 |
| 2006-06-01 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 600 | 3.85 | 2,310 |
| 2006-05-31 | Eagle J Breckenridge (Chairman of the Board) | Sale | 1,800 | 20.07 | 36,126 |
| 2006-05-30 | Stanski Don (Director) | Sale | 8,000 | 20.69 | 165,520 |
| 2006-05-30 | Stanski Don (Director) | Option Ex | 8,000 | .20 | 1,600 |
| 2006-05-30 | Eagle J Breckenridge (Chairman of the Board) | Sale | 200 | 20.91 | 4,182 |
| 2006-05-26 | Eagle J Breckenridge (Chairman of the Board) | Sale | 13,392 | 20.95 | 280,782 |
| 2006-05-24 | Eagle J Breckenridge (Chairman of the Board) | Sale | 6,908 | 21.07 | 145,551 |
| 2006-05-23 | Mahoney James J Jr (Director) | Buy | 2,000 | 22.00 | 44,000 |
| 2006-05-23 | Eagle J Breckenridge (Chairman of the Board) | Sale | 4,700 | 22.69 | 106,643 |
| 2006-05-19 | Eagle J Breckenridge (Chairman of the Board) | Sale | 5,000 | 24.53 | 122,650 |
| 2006-05-18 | Eagle J Breckenridge (Chairman of the Board) | Sale | 5,000 | 24.37 | 121,850 |
| 2006-05-15 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 25.00 | 75,000 |
| 2006-04-28 | Davidson Marc (VP of Engineering) | Sale | 12,916 | 27.82 | 359,387 |
| 2006-04-28 | Davidson Marc (VP of Engineering) | Option Ex | 9,583 | 5.84 | 55,993 |
| 2006-02-28 | Floyd William H (VP of Sales and Marketing) | Option Ex | 24,000 | 12.50 | 300,000 |
| 2006-02-23 | Devlin Philip (VP of Neurodiagnostics) | Sale | 2,222 | 25.84 | 57,416 |
| 2006-02-22 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 26.92 | 80,760 |
| 2006-02-18 | Eagle J Breckenridge (Chairman of the Board) | Option Ex | 25,000 | 4.20 | 105,000 |
| 2006-02-17 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 29.16 | 87,480 |
| 2006-02-16 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 28.79 | 86,370 |
| 2006-02-14 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 28.98 | 86,940 |
| 2006-02-13 | Devlin Philip (VP of Neurodiagnostics) | Sale | 3,000 | 29.74 | 89,220 |
| 2005-10-26 | Chamoun Nassib (President and CEO) | Sale | 5,000 | 33.00 | 165,000 |
| 2005-10-25 | Kelley Scott (VP and Medical Direc) | Sale | 1,320 | 32.30 | 42,635 |
| 2005-09-09 | Devlin Philip (VP of Neurodiagnosti) | Sale | 10,000 | 31.68 | 316,750 |
| 2005-08-09 | Devlin Philip (VP of Neurodiagnosti) | Sale | 10,000 | 32.95 | 329,500 |
| 2005-08-02 | Eagle J Breckenridge (Chairman of the Board) | Sale | 20,000 | 33.02 | 660,460 |
| 2005-07-29 | Manberg Paul (VP of Clinical, Reg-) | Sale | 20,000 | 33.30 | 665,980 |
| 2005-07-15 | Boston Scientific Corp (10% Owner) | Buy | 50,000 | 28.18 | 1,413,864 |
| 2005-07-14 | Boston Scientific Corp (10% Owner) | Buy | 57,677 | 28.90 | 1,666,749 |
| 2005-07-13 | Boston Scientific Corp (10% Owner) | Buy | 75,488 | 27.38 | 2,071,100 |
Insider trading activities including stock purchases, stock sales, and option exercises of ASPM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aspect Medical Systems Inc (symbol ASPM, CIK number 886235) see the Securities and Exchange Commission (SEC) website.